Efficacy of Combined Use of Everolimus and Second-Generation Pan-EGRF Inhibitors in KRAS Mutant Non-Small Cell Lung Cancer Cell LinesRenato José da Silva Oliveira, Rui Manuel Reis|International Journal of Molecular Sciences|2022Cited by 10